Pathologic response in patients receiving neoadjuvant chemotherapy for muscle-invasive bladder cancer: Is therapeutic effect owing to chemotherapy or TURBT?
刊名:Urologic Oncology: Seminars and Original Investigations
出版年:2017
出版时间:January 2017
年:2017
卷:35
期:1
页码:34.e17-34.e25
全文大小:612 K
卷排序:35
文摘
We estimate that 38% of pathologic response in patients who receive NAC for muscle-invasive bladder cancer can be attributed to TURBT. Patients who progressed from non-muscle invasive cancer were less likely to respond to TURBT. Identifying which patients respond to NAC and which respond to TURBT is needed to improve the effectiveness of both interventions.
NGLC 2004-2010.National Geological Library of China All Rights Reserved.
Add:29 Xueyuan Rd,Haidian District,Beijing,PRC. Mail Add: 8324 mailbox 100083
For exchange or info please contact us via email.